Literature DB >> 7067141

The determination of oxalic acid in plasma and urine by means of capillary gas chromatography.

B G Wolthers, M Hayer.   

Abstract

A gas chromatographic procedure for determining oxalate in plasma is described, in which the trimethylsilyl derivative of oxalate is analyzed on a 25-m capillary SE-30 column. In addition the effects of standing of whole blood or plasma and the effect of added glyoxalate on the oxalate concentration were studied. The present method offers good specificity and sensitivity and is easy to perform, in contrast to most methods hitherto described. The normal value of plasma oxalate was found to be 2.8 +/- 1.1 mumol/l (mean +/- 1 SD), which is close to the values obtained with in vivo tracer studies. Plasma oxalate values before and after haemodialysis are presented. By introducing a few minor modifications the method is also applicable to urine samples and in principle it should be possible to determine the glycollic acid concentration as well, both in urine and plasma.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7067141     DOI： 10.1016/0009-8981(82)90080-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  11 in total

1.  The oxalate level in ultrafiltrate fluid collected from a dialyzer is useful for estimating the plasma oxalate level in hemodialysis patients.

Authors:  Makoto Ogi; Ryoetsu Abe; Tomohito Nishitani; Masanori Wakabayashi; Tsunemichi Wakabayashi
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.801

2.  A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.

Authors:  Bernd Hoppe; Patrick Niaudet; Rémi Salomon; Jérôme Harambat; Sally-Anne Hulton; William Van't Hoff; Shabbir H Moochhala; Georges Deschênes; Elisabeth Lindner; Anna Sjögren; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2016-12-06       Impact factor: 3.714

3.  [Type I oxalosis in childhood--studies within the scope of terminal renal failure in the child].

Authors:  M Frosch; E Kuwertz-Bröking; M Bulla; D B von Bassewitz; D B Leusmann
Journal:  Klin Wochenschr       Date:  1989-11-17

4.  Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.

Authors:  E M Worcester; Y Nakagawa; D A Bushinsky; F L Coe
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function-data from three placebo-controlled studies.

Authors:  Dawn S Milliner; Pierre Cochat; Sally-Anne Hulton; Jerome Harambat; Ana Banos; Bastian Dehmel; Elisabeth Lindner
Journal:  Pediatr Nephrol       Date:  2021-01-30       Impact factor: 3.714

6.  Intra-operative continuous renal replacement therapy during combined liver-kidney transplantation in two patients with primary hyperoxaluria type 1.

Authors:  Casper F M Franssen; Ido P Kema; Douglas J Eleveld; Robert J Porte; Jaap J Homan van der Heide
Journal:  NDT Plus       Date:  2011-02-10

7.  A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.

Authors:  Joke I Roodnat; Anneke M E de Mik-van Egmond; Wesley J Visser; Stefan P Berger; Wilbert A G van der Meijden; Felix Knauf; Madelon van Agteren; Michiel G H Betjes; Ewout J Hoorn
Journal:  Transplant Direct       Date:  2017-11-08

8.  A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.

Authors:  Dawn Milliner; Bernd Hoppe; Jaap Groothoff
Journal:  Urolithiasis       Date:  2017-07-17       Impact factor: 3.436

9.  Oxalate deposition in renal allograft biopsies within 3 months after transplantation is associated with allograft dysfunction.

Authors:  Malou L H Snijders; Dennis A Hesselink; Marian C Clahsen-van Groningen; Joke I Roodnat
Journal:  PLoS One       Date:  2019-04-16       Impact factor: 3.240

10.  Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood.

Authors:  Kevin Berendse; Marc Engelen; Sacha Ferdinandusse; Charles B L M Majoie; Hans R Waterham; Frédéric M Vaz; Johannes H T M Koelman; Peter G Barth; Ronald J A Wanders; Bwee Tien Poll-The
Journal:  J Inherit Metab Dis       Date:  2015-08-19       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.